$22.335 arrow  Change: 0.32 %Chge: 1.43% Vol: 403,782
End Of Day Prices
High: 22.65 | Low: 22.22 | Open: 22.65 | Close: 22.335
52 Wk High: 24.42 | 52 Wk Low: 8.34 | Todays Pivot: 22.40
Sector: Healthcare and Pharmaceuticals add stock to watch list

VRX Chart

You need Flash Player to see the chart, please download from the link below

Get Adobe Flash player

Related Healthcare and Pharmaceuticals Companies

Cooper 73.67 green arrow 33,837
Vertex Pharmaceuticals 88.93 red arrow 146,741
Quest Diagnostics 54.53 green arrow 981,200
Life Technologies 63.65 green arrow 321,287
Gilead Sciences 67.44 green arrow 582,667
Quest Diagnostics 58.55 red arrow 60,196
Merck 46.32 green arrow 969,587
Salix Pharmaceuticals 135.07 green arrow 153,491

Above is a small selection of related companies to Valeant Pharmaceuticals Intl I which compete alongside VRX within the Healthcare and Pharmaceuticals sector. To see more related companies to VRX, view our stock market today information page.

Online News For Valeant Pharmaceuticals Intl I

Is Valeant Pharmaceuticals International Inc (NYSE:VRX) A Buy At Its Current PE Ratio?

Valeant Pharmaceuticals International Inc (NYSE:VRX) is trading with a trailing P/E of 5.6x, which is lower than the industry average of 24.2x. Although some investors may jump to the conclusion that this is a great buying opportunity, understanding the ...

Valeant Pharmaceuticals Intl (VRX) Given New $27.00 Price Target at TD Securities

"Ultimately, through all this investigation into the company's performance the analyst decides whether their stock is a "buy", sell" or hold". Causeway Capital Management Llc who had been investing in Sm Energy Co for a number of months, seems to be less ...

Valeant Pharmaceuticals Intl (VRX) Rating Reiterated by Wells Fargo & Co

The specialty pharmaceutical company reported $1.04 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.90 by $0.14. Important factors to focus when evaluating a stock's present and future value are the 52 week price high and ...

Valeant Pharmaceuticals International, Inc. (VRX) closed the last trading session at $22.7

BidaskClub upgraded Huntington Bancshares from a "hold" rating to a "buy" rating in a research note on Wednesday, January 10th. Stelliam Limited Partnership has invested 1.12% of its portfolio in Huntington Bancshares Incorporated (NASDAQ:HBAN).

Valeant Pharmaceuticals Intl Inc (VRX) Spurs Sidelined Analyst to Boost Price Target

Valeant Pharmaceuticals Intl Inc (NYSE:VRX) is eliminating risk clouds that were once hovering ominously above left and right. First, in the last few months alone, the biotech giant has made meaningful headway in advancing its pipeline. Second, the ...

Want To Add This Quote To Your Site?

With our stock widgets you can add a Valeant Pharmaceuticals Intl I quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for VRX to choose from. Visit here to build your stock quote widget »